You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Occult Hepatitis B infection

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Occult Hepatitis B Virus Infection(OBI) in Chronic Hepatitis

Recruiting
  • Chronic Hepatitis b
  • test of HBV DNA
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an JiaotongUniversity
Mar 28, 2022

Occult Hepatitis C Virus Infection in Patients Born Before 1969

Not yet recruiting
  • Hepatitis C, Chronic
  • +2 more
  • Meridan Bioscience Point of Care test against HCV antibodies
  • (no location specified)
Apr 2, 2023

Hepatitis B, Osteoporosis, Osteoporosis Risk Trial (Patient Participation Form)

Not yet recruiting
  • Hepatitis B
  • +2 more
  • Patient Participation Form
  • (no location specified)
Mar 3, 2023

COVID-19 Infection and Its Clinical Prognosis in Chronic

Recruiting
  • Chronic Hepatitis B
  • COVID-19 Infection
  • Beijing, Beijing, China
    Department of Hepatology Division 2, Beijing Ditan Hospital
Mar 28, 2023

Hepatitis Flare in Previous Hepatitis B Virus Exposure Amongst

Terminated
  • Occult Hepatitis B
  • +2 more
    • Hong Kong, Hong Kong
      The Chinese University of Hong Kong
    Jan 14, 2022

    Chronic Hepatitis B and Hepatitis D Co-infection Trial in Changchun (HH-003 20mg/kg, HH-003 3mg/kg)

    Active, not recruiting
    • Chronic Hepatitis B and Hepatitis D Co-infection
    • HH-003 20mg/kg
    • HH-003 3mg/kg
    • Changchun, Jilin, China
      First Hospital of Jilin University
    Dec 30, 2022

    Chronic HBV Infection Trial in Shenzhen (Peginterferon alfa-2b combined and ETV)

    Recruiting
    • Chronic HBV Infection
    • Peginterferon alfa-2b combined and ETV
    • Shenzhen, China
      Shenzhen Third People Hospital
    Mar 19, 2023

    Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNa Trial in Chongqing (Anti-PD-1 antibody, NAs, Peg-IFNa)

    Not yet recruiting
    • Chronic Hepatitis b
    • +2 more
    • Anti-PD-1 antibody
    • +2 more
    • Chongqing, Chongqing, China
      The 2nd affiliated Hospital of Chongqing Medical University
    Mar 14, 2023

    Hepatocellular Carcinoma Trial (Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle
    • (no location specified)
    Jun 12, 2023

    Chronic Hepatitis B Trial (RO7565020, Placebo, Nucleos(t)ide analogue (NUC) treatment)

    Not yet recruiting
    • Chronic Hepatitis B
    • (no location specified)
    Feb 28, 2023

    Predict Liver Fibrosis in Chronic Hepatitis B Infection

    Not yet recruiting
    • Fibrosis, Liver
    • Liver Fibroscan
    • Assiut, Egypt
      AssiutU
    Oct 2, 2022

    Chronic Hepatitis b, Anti-PD-1 Antibody Trial in Chongqing (Anti-PD-1 antibody, NAs)

    Not yet recruiting
    • Chronic Hepatitis b
    • Anti-PD-1 Antibody
    • Anti-PD-1 antibody
    • NAs
    • Chongqing, Chongqing, China
      The 2nd affiliated Hospital of Chongqing Medical University
    Mar 3, 2023

    Hepatitis B, Chronic Trial in Auckland (VIR-3434, VIR-2218, TDF)

    Recruiting
    • Hepatitis B, Chronic
    • Auckland, New Zealand
    • +1 more
    Dec 19, 2022

    Hepatitis B, Chronic Trial in Toronto (Tenofovir disoproxil fumarate)

    Active, not recruiting
    • Hepatitis B, Chronic
    • Tenofovir disoproxil fumarate
    • Toronto, Ontario, Canada
      University Health Network - Toronto General Hospital
    Nov 1, 2022

    Vaccination Reaction, Hepatitis B Virus Infection, Digestive System Disorders of Fetus and Newborn Trial in Chongqing

    Recruiting
    • Vaccination Reaction
    • +4 more
      • Chongqing, Chongqing, China
        Children's Hospital of Chongqing Medical University
      Sep 7, 2023

      Burden of Hepatitis D Virus Infection in China Through

      Not yet recruiting
      • Hepatitis D
      • +3 more
      • HDV-Ab (IgG), HDV-RNA, RNA genotype
      • (no location specified)
      Nov 1, 2022

      Hepatitis B, Chronic, Hepatitis D Trial in Chisinau, Kyiv (ATI-2173, Viread, AB-729)

      Terminated
      • Hepatitis B, Chronic
      • Hepatitis D
      • Chisinau, Republic Of Moldova, Moldova, Republic of
      • +1 more
      Nov 15, 2022

      Hepatitis b Virus Trial in Bangkok (HBV vaccine)

      Completed
      • Hepatitis b Virus
      • HBV vaccine
      • Bangkok, Thailand
        HIV-NAT Thai Red Cross AIDS Research Center
      Jul 15, 2020

      Hepatitis b Virus Trial in New York (HepB mAb19, Sterile Saline)

      Not yet recruiting
      • Hepatitis b Virus
      • HepB mAb19
      • Sterile Saline
      • New York, New York
      • +1 more
      May 12, 2023

      Hepatitis B Virus, Health Care Associated Infection Trial in Kalulushi (Engerix-B)

      Completed
      • Hepatitis B Virus
      • Health Care Associated Infection
      • Engerix-B
      • Kalulushi, Copperbelt, Zambia
        Kalulushi district all facilities
      Jul 19, 2022

      Hepatic Steatosis and Chronic Hepatitis B Virus

      Not yet recruiting
      • Chronic Hepatitis
      • Liver biopsy
      • Sohag, Egypt
        Faculty of medicine
      Dec 28, 2022

      Hepatitis C Virus Infection

      Active, not recruiting
      • Hepatitis C
      • Hepatitis B
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Dec 30, 2022

        HBV Infection, Chronic Hepatitis b Trial in China (Tenofovir Amibufenamide(TMF))

        Recruiting
        • HBV Infection
        • Chronic Hepatitis b
        • Tenofovir Amibufenamide（TMF）
        • Beijing, China
        • +11 more
        Mar 22, 2023

        Chronic Hepatitis B Trial in Hamburg (HEPLISAV B; TherVacB, TherVacB)

        Not yet recruiting
        • Chronic Hepatitis B
        • HEPLISAV B; TherVacB
        • TherVacB
        • Hamburg, Germany
          CTC North
        Feb 3, 2023

        Hepatitis B Trial in Cambridge (GSK3965193, Placebo to match GSK3965193, Bepirovirsen)

        Recruiting
        • Hepatitis B
        • Cambridge, United Kingdom
          GSK Investigational Site
        Jun 14, 2022